PandemiCam – Our greatest chance yet to detect, monitor and beat COVID-19



Spinview logo

Spinview Global Limited

VR Media Tech

VR Media Tech

In seconds, PandemiCam can, using a proven successful matrix of sensors, identify a wide range of symptoms to indicate infection.

Mathematics and Artificial Intelligence are two of the most effective weapons we have in the fight against the coronavirus outbreak”

— Dr Katarina Gospic, leading Neuroscientist

LONDON, UNITED KINGDOM, March 27, 2020 / — If not the deadliest, the novel coronavirus (COVID-19) is certainly the most serious contagious disease to have crossed continents in modern times. One of the biggest challenges is screening en-masse for detection of infectious individuals. Today’s current methods are rudimentary (measuring only temperature) or very expensive and time consuming (swab test). Detecting infectious people at an early stage is key for disease control and management.

A joint venture between Spinview ( and VR Media Technology (, has created an effective weapon against coronavirus. In seconds, Spinview’s revolutionary device, PandemiCam can, using a proven successful matrix of sensors, identify a wide range of symptoms to indicate infection.

Once the device is installed, unlimited tests can be performed without having to rely on consumable materials. The device is able to operate en-masse and report to a central server for infection monitoring and tracking. Accuracy is much higher than with non-contact thermometers, as the system can scan thousands of measurements per second across an entire spectrum of sensors, including, but going well beyond, only temperature.

COVID-19 is known to affect physiological parameters such as temperature, respiration, hydration, sweating, flushing and coughing. PandemiCam is a non-invasive multi-sensory device which is designed to collect information from multiple sensors to ‘read’ the COVID-19 symptom parameters in every person it scans.

PandemiCam combines the use of mathematics and artificial intelligence (AI) with pre-existing sensors into one revolutionary scanning unit enabling widespread screening with ease. The collected data is fused together by the system and feed through AI, to provide an accurate and fast detection of infectious people with far greater clarity than any single parameter test available today.

Appropriately named PandemiCam, this complex scanning system can help authorities across the globe limit the spread of COVID-19, assisting in the management of precious healthcare resources in real-time.

“Mathematics and Artificial Intelligence are two of the most effective weapons we have in the fight against the coronavirus outbreak” Dr Katarina Gospic, leading Neuroscientist

Where current single parameter tests such as temperature have to be measured individually, PandemiCam is able to screen groups of people and even scan at a distance for the safety necessitated by this particular disease. Against a city grid, PandemiCam allows for the real-time mapping of symptoms. Quick identification of hotspots allows for localised restrictions and resource allocations, reducing financial damage and human danger. Continuous en-masse screening is key to winning the battle against coronavirus.

In the US there are currently 65,000 tests being conducted per day (source: Even if they were able to increase this to 100,000 per day, in order to cover the entire US population of those over the age of 18 (330 million) it would take 7 years.

The more we can repeatedly screen population(s), the better we will be at detecting infectious people and thus slowing and limiting the rate of spread.
Spinview’s screening would bring that figure down and enable mass screening and information on its spread in seconds. The system will alert healthcare professionals to identify those in need of treatment instantly – no waiting for lab results. Medical staff can carry out predictive triage – understanding based on the data received, correlated with the known passage of the disease through the system, what a patient is likely to experience and the support they will need. The system could also be used to ensure the health and wellbeing of the general public in order to resume freedom of movement. By using the device within public transport and infrastructure systems such as airports including it as part of their security checks, it could help keep airports free of COVID-19 or other diseases. This would ensure that future outbreaks could be contained and monitored more effectively while keeping the economy going and people moving.
In simple terms, PandemiCam scans en-masse, in seconds and will save lives.

For more information on PandemiCam please contact

About Spinview and VR Media Technology

Spinview Global Limited ( a UK based company with offices in London, (UK) Stockholm (SE), Belgrade (RS) and Los Angles (CA, US) that creates high-performance software and hardware for a variety of infrastructure needs.

Spinview offers solutions that combine volumetric data capture, multi-sensor data fusion, and sophisticated data automation to create dynamic digital twins of real-world situations and environments which are useable and accessible across an entire organisation. Spinview has been developing a set of volumetric visualization tools for these industrial applications, specifically digital scanning.

Specialising in the creation of cutting-edge sensor, scanner and hardware configurations tightly joined to powerful proprietary software control.

VR Media Technology ( mixes science and art to produce unique products in the field of image computing. The compete hard and move fast to create new products in emerging markets and have a long history of providing precise diagnostic solutions to the healthcare industry.

Spinview, together with VR Media Technology, have developed PandemiCam (symptomology of Pandemic detection scanner) which would allow healthcare professionals as well as commercial or governmental users to achieve quick and reliable detection of individuals who might be carrying a contagious disease.

Greg Passmore, CTO at VR Media Technology, says: “Multichannel fusion with neural net convergence is clearly the path we need, to more accurately identify symptoms of interest. This will allow everyone to focus resources where most needed and understand finely localized clusters and transmission paths. We will look back years from now and shake our heads at the insanity of using $100 thermometers to address a multi-trillion-dollar disaster”

Dr Katarina Gospic, Director of Neuroscience at Spinview says, “Screening for infection with our technology could make everyone in the world feel safe again. Societies would open up and the wheels of the world economy would spin again. We could all go back to our normal life." She adds, "It is absolutely amazing that our invention can give real time information about the general health status of a population. The more frequently we can screen for infection in the case of corona, the better we will be at limiting spread."

Linda Wade
Spinview Global Limited
+44 7801 881923
email us here
Visit us on social media:

Source: EIN Presswire

Gotham Footcare is Helping New Yorkers Stop the Spread of Covid-19 While Still Taking Care of their Patients.

Gotham Footcare - New York - COVID19

Gotham Footcare does it’s part in keeping their clients safe.

Gotham Footcare is doing all it can to maintain the health of New York and their patients.

NEW YORK , NEW YORK , UNITED STATES, March 27, 2020 / — During these difficult times and all the challenges that we are currently facing with CoronaVirus, as New Yorkers and as a nation, what we are missing the most right now is the ability to humbly serve and treat you – our patients!

As a medical practice, Gotham Footcare is considered to be an essential business during this pandemic crisis. However, as of March 23rd, 2020 I have decided that it is my moral obligation to voluntarily shut down Gotham Footcare except for emergency visits, for the time being to help stop the spread of COVID-19. This was a tremendously difficult decision to make as I appreciate each and every one of you, but a necessary one, so that we may conquer COVID-19 together. We will certainly overcome these trying times; it is not a a question of if, but of when, and we will prevail together more rapidly if we are all socially responsible and avoid unnecessary social interaction. Until then we will continue to make ourselves physically available to you for emergency visits only.

In the mean time, we are proud to announce that Gotham Footcare is now offering Telemedicine sessions that require no out of pocket cost to our insured patients. We will also work with you if you do not have insurance. Whether you are facing a new foot health issue, need a prescription refill, discuss lab results, have questions about how to properly maintain your current treatment regimen, or need to speak with our highly qualified podiatrists, we are here to help! Simply visit to book your video appointment today.

Ana Couto
Gotham Footcare
+1 212-921-7900
email us here

Source: EIN Presswire

William Magagna Named Treasurer of LTEN Board of Directors

Life sciences training veteran William Magagna has been selected as treasurer of the LTEN Board of Directors.

ROANOKE, VA, UNITED STATES, March 27, 2020 / — Life sciences training veteran William Magagna has been selected as treasurer of the LTEN Board of Directors. The appointment, which begins immediately, runs through the end of 2021. Magagna succeeds Richard Sampson, who was named 2020-21 president of the LTEN Board of Directors.

Magagna, vice president, virtual education solutions, for Siemens Healthcare, has worked in virtual education and instructional design for more than 25 years, including the past 17 years with Siemens. Magagna has served on the LTEN Board of Directors since 2012.

“I was happy to step into the treasurer role after Richard’s selection as board president,” Magagna said. “After eight years on the board, I’ve seen how vital that role is to the management of our network and how much it affects members in ways they may not even realize. I look forward to working closely with the board, other officers on the board’s Executive Committee and LTEN staff to ensure we’re compliant, fiscally responsible and forward-thinking in our resource management.”

“Bill’s been a valued member of LTEN and of the board for a long time, and I know he’ll be a great asset to the leadership team,” said Dawn Brehm, LTEN executive director. “The treasurer role is a vital one, and Bill’s experience, reliability and attention to detail will serve LTEN well.”

The Life Sciences Trainers & Educators Network ( is the only global 501(c)(3) nonprofit organization specializing in meeting the needs of life sciences learning professionals. LTEN shares the knowledge of industry leaders, provides insight into new technologies, offers innovative solutions and communities of practice that grow careers and organizational capabilities. Founded in 1971, LTEN has grown to more than 2,100 individual members who work in pharmaceutical, biotech, medical device and diagnostic companies, and industry partners who support the life sciences training departments.

For more information contact Nannette Nolan, LTEN director of marketing communications, at

Nannette Nolan
Life Sciences Trainers & Educators Network
+1 424-266-0745
email us here
Visit us on social media:

Source: EIN Presswire

Dr. Steven F. Weiner is Rated As One Of The Top 1% Of Physicians Who Treat Acne Scars

Using filler and subcision for acne scars Dr. Steven F. Weiner, MD

Treatment with Bellafill and Subcision

Filler, subcision, and RFM for acne scars, Steven F. Weiner, MD

Treatment with Subcision, Filler, and the Genius RFM Steven F. Weiner, MD

Dr. Weiner and his team treat acne scar patients from all over the world with a multifaceted, comprehensive approach for all degrees of scarring and skin types.

Dr. Weiner uses a combination of treatments for acne scars including Radiofrequency Microneedling, Subcision, TCA CROSS, Dermal Fillers, and Lasers to obtain optimal results.”

— Steven F. Weiner, MD

SANTA ROSA BEACH, FLORIDA, UNITED STATES, March 27, 2020 / — Dr. Steven F. Weiner is a Facial Plastic Surgeon in Santa Rosa Beach, Florida who has been rated as being within the "Top 1% of Physicians" who treat acne scars. Dr. Weiner and his team routinely see patients daily from all over the United States, Canada, and across the world for treatment of their acne and acne scars.

Typically, patients have already performed an online consultation and a tentative treatment plan has been outlined, prior to their office visit. These consultations can be arranged through our office by calling 850.622.1214. Instructions are given to upload photos to our HIPAA compliant cloud based software, TouchMD. Upon review, Dr. Weiner gives his opinion as to what methods of treatments would generate the best results. Appropriate considerations are made based on patient's skin type and tolerable downtime. Final treatment plans can only be determined by the in-office consultation and physical exam face-to-face with the patient.

Acne scars are grouped into 3 types: Atrophic/Rolling acne scars, Boxcar scars, and Ice Pick scars. Each type of scar is treated differently by Dr. Weiner and often combination treatments will give the best results.

The types of treatments offered for acne scars are:

Subcision: Using blunt microcannulas, scars that are tethered from the skin (dermis) to the deeper tissues are released by dividing them. Using cannulas has been shown in studies to be more effective, have less side effects, and more patient satisfaction than the traditional methods used for subcision such as the Nokor needle. There is minimal pain and swelling typically with this treatment and usually a numbing agent is injected simultaneously when performing subcision.

TCA CROSS: TCA is a chemical peeling agent that leads to collagen stimulation during the healing process. CROSS stands for chemical reconstruction of skin scars. Using 80-100% TCA, ice pick or select small boxcar scars are treated with this technique. Small scabs form after this treatment and can last about 5 days. It is important to keep these scabs moist for best results. Literature states that 4-6 treatments are needed for best results and that improvement in these scars is very significant.

Radiofrequency Microneedling (RFM): RFM is a technology that Dr. Weiner embraced ever since it was introduced to the United States in 2013. Dr. Weiner has become one of the world's authority on RFM and recently published a chapter: Radiofrequency Microneedling: Overview of Technology, Advantages, Differences in Devices, Studies in Facial Plastics Clinics of North America. RFM is used to treat all types of acne scars by remodeling the scars and producing collagen, elastin, and hyaluronic acid. Many of the acne scar patients are darker skin types and RFM is a very safe treatment for all colors of skin. Dr. Weiner's choice of RFM device is the Genius from Lutronic. It is the most advanced RFM on the market with features such as: impedance feedback, insulated needles, pulse quality feedback, energy delivered, and variable pulse/depth. Due to the features of the Genius, downtime is minimized, results are optimized, and the treatment is extremely safe. "Our patients will often fly in and fly out on the same day they receive treatment with the Genius". Usually 3 of these treatments are performed.

Lasers: There is a full complement of ablative and nonablative lasers at The Aesthetic Clinique. While nonablative offer some improvement with acne scars, the most appreciable results are obtained with the ablative lasers, specifically, the CO2 laser. Dr. Weiner uses the eCO2 laser as his choice for acne scars. This laser is reserved for skin types 1-3 (lighter skin) because darker skin has a risk of post inflammatory hyperpigmentation (PIH). There is about 5-7 days of wound care and being housebound after this treatments. This laser is a fractional CO2 laser which makes it safer than the older CO2 lasers. 1-2 treatments are usually performed.

Fillers: When there is volume loss or depressions related to acne scars, often fillers are used to elevate the scars. Sometimes the volume loss associated with aging accentuates the visibility of acne scars and this requires filler as well for best results. Dr. Weiner uses a variety of fillers to treat acne scars: Hyaluronic Acid (Restylane Refyne, Defyne, Lyft) and Polymethylmethacrylate (Bellafill). The specific filler used during a treatment is determined by the duration desires of the patient as well as the best filler for their particular scar. Filler treatment is often combined on the same day as all the above treatments.

Low Level Laser Treatment (LLLT): All patients are treated with the Healite after lasers or RFM. This light leads to better results, faster recovery, and less redness which has been proven by multiple studies. This complimentary treatment is 17 minutes, painless, and relaxing. The day after treatment, we also offer another treatment if the patient is still in town.

Dr. Weiner individualizes his acne scar treatments and uses a team approach to give patients the optimal results. Keep in mind that multiple treatments are the norm, often every 4-8 weeks.

Dr. Weiner positions his practice, The Aesthetic Clinique, as one of the most technologically advanced cosmetic centers in the United States. Dr. Weiner lectures and trains worldwide on advanced injection techniques and aesthetic technologies. The Aesthetic Clinique was awarded the Best Aesthetic Practice in the U.S. in 2018 at The Aesthetic Show. In 2019 and 2020, The Aesthetic Clinique was voted Best Medspa and Best Doctor from The Best in Destin awards. He is one of the world's authorities on Radiofrequency Microneedling and recently published the most comprehensive review of the technology and studies in the Facial Plastic Surgery Clinics of North America. He was recently highlighted on "The Doctors Show" for his trademarked "reJAWvenation" technique for jawline rejuvenation using dermal fillers. Dr. Weiner has over 26 years of experience in the aesthetic industry.

Steven Weiner
Aesthetic Clinqiue
+1 850-622-1214
email us here
Visit us on social media:

Dr. Weiner shows his subcision technique followed by Genius (RFM) and Healite

Source: EIN Presswire

Elizabeth Stanton, The Worldwide Spokesperson for Popstar!, Addresses Young People at Risk of Coronavirus

Elizabeth Stanton,The Worldwide Spokesperson for Popstar!

“Nobody should feel invulnerable to the coronavirus. Young people are going to contract the disease.” – Elizabeth Stanton

LOS ANGELES, CA, UNITED STATES, March 27, 2020 / — Despite health officials’ pleas to stay home and avoid spreading the coronavirus, young people have been packing beaches & hiking trails, picnicking in parks, and flying to far-flung destinations on the cheap. But as the pandemic rackets up with 417,000 cases and counting across the world, it is becoming increasingly apparent that coronavirus affects large numbers of people below 50. In New York City, health officials said that of 1,160 people hospitalized with COVID-19 symptoms, one in four were between ages 18 and 49. Across the United States, about 38% of coronavirus patients sick enough to be hospitalized were ages 20 to 54, the CDC reported last week.

Young people need to realize the magnitude of the situation and must take this seriously. Thankfully, some individuals and organizations are here to reach out to young people, giving them factual reality checks on the pandemic. The Popstar! Network has much to say on the matter along with Elizabeth Stanton, the Worldwide Spokesperson for Popstar!.

Check out Elizabeth Stanton’s thoughts below:

Currently, a novel coronavirus, SARS-CoV-2, is spreading across the globe, causing a new coronavirus disease, or COVID-19. Nobody should feel invulnerable to the coronavirus. Young people are going to contract the disease as well. The rates of severe and deadly cases might not be nearly as high as the elderly, but the data already show that age alone does not make you invincible. If you do find yourself infected, call a doctor immediately and follow the same rules that those who wish to remain healthy follow. Is there any good news? Well, take the proper steps in treatment and prevention is possible. Most people with the COVID-19 virus have a mild disease and recover.

People with COVID-19 generally develop signs and symptoms, including mild respiratory symptoms and fever, on an average of 5-6 days after infection and can last up to 14 days. If you have any pre-existing respiratory conditions, such as asthma, you need to take isolation and shelter at home very seriously as that is the most effective way to stay healthy. If you have had or have heart disease, diabetes, high blood pressure, lung disease, or cancer, you must take extra precaution. If you must go out, take gloves at the very least or hand wipes in case you have to get gas or groceries. Wipe down the gas pump where you enter your information as well as the handle itself. If you are grocery shopping, absolutely wipe down all grocery cart handles.

The Popstar! Network will use our vast resources and significant reach to inform the millennial population about this emergency and provide daily updates. We will continuously share information and encourage our audiences to be responsible and careful about social distancing and not spreading the virus. Our up-to-the-minute news we present is visually-captivating, compelling and specifically designed for millennials and the millennial-at-heart. The Popstar! Media Network is the perfect, all-in-one lifestyle companion which includes streaming media, digital and print magazines, TV shows, radio, a website, events and very robust social media presence. In regard to this COVID-19 crisis, we are in this together and we’ll get through this together.

All of us at POPSTAR! care about what is going on, and we have the resources for you to check information on regarding what is happening in the world. Our wonderful Vice President of Popstar!, Jacob Mayberry, has a message for everyone: “The POPSTAR! Network delivers an enthusiastic ecosystem with the most current pop culture news from across the globe with detailed information on celebrities, fashion, music, health, beauty and everything in between. We are proud to have the eyes and ears of millions of people. We will continue to adapt and evolve with the pop culture landscape and provide vital information in a world where misinformation is so present.”

POPSTAR!’s ever-growing audience of 8.2+ million are engaged throughout our media platforms and our website generates over 500,000 weekly visitors. With our print and digital magazines, we reach over 385,000 households 6 times a year. POPSTAR!'s streaming radio station reaches 147,000 listeners a day with our streaming media, of over 800 hours of content, reaches an audience over 500,000 monthly. Our TV programs reach 3 million and include specials, such as our annual prime time POPSTAR!’s “Best Of” on The CW. POPSTAR!’s social media engagement reaches over 4.2 million people a month.

Get the latest news at:


Elizabeth Stanton

Elizabeth Stanton has been a world traveler her entire life, experiencing the culture of Europe, the wonders of the Far East, and the natural beauty of remote destinations. She started hosting “Elizabeth Stanton’s Great Big World” at the age of 15, and it was watched in 90% of the United States at its peak and is the top-rated show on FOX affiliates nationwide. In the show, she travels the globe with her celebrity friends exploring other cultures, learning about history, and finding opportunities to help those in need, while shedding some light on what others less fortunate are dealing with. The show featured stars like Bailee Madison, Jake T. Austin, Gregg Sulkin, and Anna Maria Perez de Tagle, and filmed in places all over the world, from the USA to Nicaragua to Paris to Beijing. She continues to film new episodes of Great Big World, which has been running for nine years and this is now the 10th year in which it continues to remain strong.

Elizabeth is very passionate about giving back and is a supporter of Marines Toys for Tots Foundation, donating thousands of toys to the organization over the last few years. In addition, she has donated money earned from her show to the homeless men, women, and children of Los Angeles, ultimately helping to feed over 4000 families in Los Angeles for two months.

Aurora DeRose
Michael Levine Media
email us here

Source: EIN Presswire

A 3-Step Plan to Save Lives

Surgical gloves and mask and home-based blood test kit.

As John Norris explains, we urgently need three tools to defeat Covid-19.

When we tell the story of this time, let no one say that we gave nothing less than our best to save American lives.

BOSTON, MASSACHUSETTS, UNITED STATES, March 27, 2020 / — American ingenuity and determination are the key ingredients needed to win the battle against the coronavirus. With the greatest scientific minds in our midst, and the political will to execute on an ambitious plan, there is no reason we cannot defeat the virus in a matter of months.

The plan that I have devised requires the manufacture and distribution of three products and the commitment by a majority of Americans to their consistent use. With the support of the U.S. President and all 50 governors, this plan could easily help to save at least 50,000 American lives.

Not insignificantly, it could also help restore our economy.

American lives – young or old, disabled or immunocompromised, or the picture of health – are not expendable. They are not to be accepted as “collateral damage.” When we tell the story of this time, let no one say that we gave nothing less than our very best to save American lives.

I have spent my professional life in the service of public health, having previously served as the Principal Deputy Commissioner of the U.S. Food and Drug Administration and as a health policies and management faculty member at Harvard. I now serve as Executive Chairman of FDTH Regulatory Affairs Strategies, which provides healthcare strategic advisory services worldwide.

The coronavirus is a global public health challenge unlike any we have faced in decades. Like most unfathomably difficult projects, it must be broken down into smaller, manageable steps.

The recommendations described below would be in addition to the current precautions we are already taking:
• Regular, thorough hand-washing
• Disinfection of frequently used surfaces
• In-home quarantine or, if needed, hospitalization of the infected

I also recommend the deployment of three additional tools.

If even half of all Americans wore highly protective gloves whenever outside their home, the “touching-transfer” of the disease, both direct and indirect, would be cut significantly.

Produced in the tens of millions, the cost of these gloves would dramatically be reduced. Each household would need one pair per person, per month. Let’s start with three months but be prepared to extend it another three months.

If half of all Americans also wore surgical-grade masks whenever outside their home, sneezing and coughing transfer, both direct and indirect, would be reduced.

Produced in the tens of millions, the cost of these masks would dramatically be reduced. Each household would need four masks per person per month, changing masks weekly. Assuming each person’s workplace is kept virus-free, the masks would only have to be worn when they are outside work or home.

The lack of testing capacity has been identified as our primary weakness in this battle, because we don't know who has it, but is either not sick yet or is just an asymptomatic carrier. The availability of an in-home, high-speed (from start to finish) test would be revolutionary.

It is safe to assume that the greatest scientific minds in our country are already working on bringing such a test to market. They will, of course, require expedited funding and government approval, but more than any other tool in our tool bag, a widely available, high-speed test would prevent the unwitting spread to others.

Initially, these tests should be monitored, via the Internet, by a healthcare professional. Once they are observed to be roughly as safe and effective as an in-home blood sugar tests used by diabetics, the tests could be fully self-administered, saving the healthcare delivery system billions.

The plan I have outlined would require the consistent, committed use by every household who volunteers to take part. They would be asked to commit to themselves and their housemates to wearing the gloves and mask every time they leave their homes.

And, every time they return they would be asked to hang up their mask and gloves and test themselves, as well as others seeking entry to their home.

The number of households likely to be involved here is around 64 million of the 128 million households in America. Each of these typically house three residents. In other words, a total of 192 million Americans, or roughly 60% of our 330 million-person population.

For distribution, the U.S. Postal Service has the capacity to distribute 30-million packages per day. It will take only nine days to distribute all three items.

As soon as the initial steps are started, the more successful this plan will be. It is estimated that the lives of some 50,000 Americans (and perhaps another 100,000 worldwide) might be saved, if the products and the device are distributed by June 30th, a possible but difficult target date to meet.

Those who say such a campaign would be prohibitively expensive should consider what the pandemic has already cost. We are already facing trillions of dollars in losses, and we have barely left the starting blocks. After calculating the likely full cost of not winning the war, soon, the real cost of doing less than we can do to win this war quickly is obscene.

The President is looking for a “Big” strategy to win this war. Hopefully, he will embrace this well-thought-through “three-legged strategic action plan” because it is likely to produce enormous benefits if it is fully employed as soon as possible.

Take a hard look, Mr. President. You, too, Governors of our 50 states. We will support you. We will have your backs. This aggressive plan might make all the difference. Nearly everyone, expert or not, agrees we need massive testing, now. This is a smart and inexpensive way to do it.
The Hon. John Norris is an FDA Former Principal Deputy Commissioner, a Harvard Former Health Policy and Management Faculty Member, and Chairman of FDTH Regulatory Affairs Strategies, as well as an inventor-entrepreneur and frequent drug, device, Healthcare-IT, clinical lab, and hospital-system visionary, innovator, advisor, and board member. He can be reached at

John Norris
FDTH Regulatory Affairs Strategies
+1 617-680-3127
email us here

Source: EIN Presswire

Transvaginal Mesh Injured Women: Pudendal Neuralgia Remains Undiagnosed

A substantial group of women have still not been diagnosed and treated for their neurological injuries.

Women who have symptoms of pudendal neuralgia…care little that the neurological diagnoses are the result of a defective product or how it all may have unfolded. They just want to get better.”

— Dr. Greg Vigna

SANTA BARBARA, CA, UNITED STATES, March 27, 2020 / — As the Transvaginal Mesh Multidistrict Litigation in the Southern District of West Virginia winds down and women are awaiting remand after their Wave Discovery has been concluded and all attempts of settlement have passed, it is clear that a substantial group of women have still not been diagnosed and treated for their neurological injuries.

Greg Vigna, MD, JD, national pharmaceutical attorney, practicing physician, and Certified Life Care Planner comments, “This is not surprising as the American Urogynecologic Society (AUGS) and American College of Obstetricians and Gynecologist (ACOG) have done nothing in terms of providing mandatory Continued Medical Education programs to educate their members about the neurological complications of the mesh which include pudendal neuralgia, obturator neuralgia, and ilioinguinal neuralgia. They’ve put their head in the sand.”

Dr. Vigna continues, “Women are awaiting remand from the MDL and they know they are severely injured from their injuries but many times have not yet seen a doctor to diagnose and treat their neurological injuries. Pudendal neuralgia, obturator neuralgia, and ilioinguinal neuralgia are serious injuries and these devices cause them. Treatment by experts in the field of vaginal mesh complications may require complete removal, nerve decompression, neuromodulation, physical therapy, and therapeutic injections.”

Dr. Vigna adds, “Women want treatment but access to care is scarce and clinical knowledge of these distinct three neurological injuries caused by vaginal mesh devices within the medical community remains largely absent because of inaction by AUGS and ACOGS and ongoing deceptive sales practices by the manufacturers. Women who have symptoms of pudendal neuralgia that I have recently connected with care little that the neurological diagnoses are the result of a defective product or how it all may have unfolded. They just want to get better."

To learn more about the neurological injuries get your copy of Dr. Vigna’s book, Chronic Pelvic Pain at

Greg Vigna, MD, JD, operates a California and Washington DC law firm and has teamed up with Martin Baughman, a national pharmaceutical injury trial law firm from Dallas, Texas, and together they represent women with catastrophic pain syndromes who are proceeding down the path of justice.

For articles, video resources, and information, visit the Pudendal Neuralgia Educational Portal ( or

Greg Vigna, MD, JD
Vigna Law Group
1155 Coast Village Rd., Suite 3, Santa Barbara, CA

Greg Vigna
Greg Vigna, M.D., J.D., PLC
+1 800-761-9206
email us here
Visit us on social media:

Source: EIN Presswire

Prefabricated Modular Hospital Isolation Rooms To Help Hospitals Due To Shortages Caused By The COVID-19 Surge

Isolation Rooms

Front view

Isolation Room with Negative Pressure HEPA Filtration & UV Light

"If proper protocol is to be followed, millions of isolation rooms may be needed.”— M.R. SECURE SALES spokesman

We have 330 million persons in the USA. In 12-18 months, 1% of the population (if tested) may be infected with COVID-19. If proper protocol is followed, millions of isolation units may be needed.”

— M.R. Secure Sales LLC Spokeman

MANALAPAN, NEW JERSEY, UNITED STATES, March 27, 2020 / — Panel Built, modular construction provider for 25 years, now offers a way for medical facilities to create and expand their infectious patient isolation areas with modular Isolation rooms. With the growing Coronavirus pandemic spreading across the United States and internationally, Panel Built’s modular isolation rooms are a convenient solution for hospitals that need to increase their single-occupancy, isolation space as quickly as possible. Using a panelized wall system, the isolation rooms are fully fabricated in Panel Built’s modular construction facilities. The components are then delivered and assembled on site. This design allows for prefabricated, quickly assembled isolation rooms that have fully customized layouts and designs.

Panel Built’s isolation rooms offer options, (where situations warrant), for HVAC systems with fan filter units (FFUs) to keep the room at appropriate temperatures and constantly filter particles with HEPA filtration and UV light from the environment’s air supply with the numerous air exchanges per hour. Unlike most manufactured clean rooms, patient isolation rooms can be customized with a negative pressure environment for patients who may have an impaired immune system and may be a carrier for other infectious diseases that are airborne spread rather than the droplet Coronavirus. Diseases such as TB, Measles, Mumps, Varicella and other respiratory infections fall into the airborne category. When the negative pressure isolation room is needed, the air pressure inside the isolation room is lower than entrance ante room to keep air flowing into the patient isolation room instead of out, keeping any contaminants or particles from escaping the room. All isolation rooms should be used in conjunction with proper staff and equipment sanitizing and hospital contamination control procedures.

Panel Built’s Steve Grzesik, Sales Manager Welded Steel Division, stated, "While Panel Built is a for-profit company, our first objective is to help our nation and others meet the challenge and help save lives. Our nation's largest hospitals and long term care centers will need all the isolation bed space they can get, and Panel Built is ready to help meet the need."

M.R. Secure Sales LLC spokesman stated the following, " There are 330 million persons in the USA. Predictions are, over the next 12-18 months, approximately 1% of the USA population (if tested) may be infected with the Coronavirus. If proper protocol is to be followed, millions of isolation rooms may be needed in the USA alone. The nations largest hospitals in total, may have fewer than several thousand isolation rooms. "
Panel Built was founded in 1995 by brothers Pat and Mike Kiernan, and began with the construction of pre-manufactured buildings. Today, Panel Built offers a complete line of custom modular offices, mezzanines, security booths, pre-assembled exterior buildings, and cleanrooms. Panel Built isolation rooms are designed 100% to customer specification and are delivered with components ready for installation. Panel Built’s main mission is, “Solving Our Customers’ Space Needs with Excellence and Great Customer Service.”

Isolation Room Brochure:

For more information, visit:

The New Generation in Modular Buildings, Enclosures & Mezzanines

Contact information:

Mike Rosenberg
M.R. Secure Sales
Limited Liability Company
Cell 732-491-5120

Steve Grzesik
Sales Manager Welded Steel Division,

Panel Built, Inc.
P.O. Box 2658, Blairsville, GA 30514
Office (706) 745-6540 TF (800) 636-3873 Fax (706) 745-1450

“M.R. Secure Sales LLC represents leaders in Modular Guard/Security/Parking Booths & Bus Shelters, Clean Rooms, Isolation rooms and Negative Pressure Infectious Disease Isolation Rooms, Offsite Sustainable Construction of Steel and Concrete Multi-Story Modular Schools, Dorms, Condos, Town Houses, Senior Housing, Hotels, Retail Stores, Emergency Care Facilities, Equipment/Telecommunication Shelters, Modular Correctional Facilities, Modular Steel Police/Jail and Prison Cells,Modular Offices within in Factories and Warehouses, and Miscellaneous Metals and Custom Steel Railings and Stairs”

+1 732-491-5120
email us at
Visit us on social media:

Michael J Rosenberg
+1 732-491-5120
email us here
Visit us on social media:

Source: EIN Presswire

COVID-19 Healthcare Industry Packaging from B2B Industrial Packaging

B2B Industrial Packaging President Bill Drake

B2B Industrial Packaging

B2B Industrial Packaging remains a trusted source of packaging materials for the healthcare industry. The company is fully operational at all of its locations.

End users, whether they are medical professionals or among the millions of people that have to work from home, need to have confidence in product packaging. ”

— B2B Industrial Packaging President Bill Drake

ADDISON, ILL., U.S., March 27, 2020 / — During the COVID-19 pandemic, B2B Industrial Packaging remains a trusted source of packaging materials for the healthcare industry. The company has been given critical industry exemption status that allows it to continue full operations at all locations in states with shelter-in-place orders.
B2B Industrial Packaging Bill Drake said, “Most people don’t think about the important role that packaging plays except during a crisis like this. Aside from protecting crucial healthcare supplies and facilitating shipment, the ecommerce we are all totally dependent on now wouldn’t be possible without sturdy, reliable packaging.”
Among the many types of protective packaging and supplies that B2B Industrial Packaging offers are: poly bags, foam packaging, corrugated boxes, edge protection, protective film, stretch film, sealing tape and steel and plastic strapping.
Many of these products meet the following needs of the healthcare industry:
• Compliance: The U.S. healthcare industry has among the strictest compliance standards in the world for packaging.
• User-Focused Design: Until recently, packaging that met strict compliance standards was not user friendly—a real issue for healthcare professionals that had to cope with difficult to open packages in an emergency. Today’s packaging meets compliance standards without sacrificing accessibility.
• Sterility Across the Supply Chain: B2B Industrial Packaging’s suppliers are continually designing solutions that improve end-to-end supply chain protection.

Drake concluded, “End users, whether they are medical professionals or among the millions of people that have to work from home, need to have confidence in product packaging. The container and packing supplies are usually the last things consumers think about, but during a crisis like this, they should be among the first.”
Servicing more than 6,000 active clients, B2B Industrial Packaging sells a full range of packaging equipment and supplies including steel strapping, stretch film, and fasteners to clients throughout the U.S. and Mexico. B2B Industrial Packaging is unique in that it also operates three state-of-the-art strapping and fastener tool repair facilities that service the entire U.S. Headquarters are in Addison, Ill. with additional locations in Fort Worth, Texas; Houston; Salinas and Hayward, Calif.; Los Angeles; Portland, Ore.; Eugene, Ore.; Seattle and Kansas City, Kan. To contact B2B Industrial Packaging, call 1-877-222-5747, email Caitlin Montgomery at, or visit For media inquiries, contact Jeanna Van Rensselar at Smart PR Communications; 630-363-8081.

Jeanna Van Rensselar/B2B Industrial
B2B Industrial Packaging
+1 877-222-5747
email us here
Visit us on social media:

Source: EIN Presswire

Carolina Liquid Chemistries Now Offers COVID-19 Rapid Screen Antibody Test

Carolina Liquid Chemistries, Corp. now offers the AllTest™ 2019-nCoV IgG/IgM Rapid Screen Antibody Test Cassette

GREENSBORO, NC, USA, March 27, 2020 / — Carolina Liquid Chemistries, Corp. (CLC), an innovative biotechnology company, now offers the AllTest™ 2019-nCoV IgG/IgM Rapid Screen Antibody Test Cassette in accordance with Sections C and D of the FDA’s March 16, 2020 “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.”

COVID-19 (Corona Virus Disease) is caused by 2019-nCoV (SARS-COV-2) which is mainly transmitted through respiratory droplets. Symptoms of COVID-19 may appear 2-14 days after exposure. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.1

The 2019-nCoV IgG/IgM Rapid Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to 2019-nCoV in human whole blood, serum or plasma specimen. The test can be stored sealed at room temperature or refrigerated. The 2019-nCoV IgG/IgM Rapid Test Cassette can be performed using whole blood (from venipuncture or fingerstick), serum or EDTA plasma (K2, Heparin sodium, Citrate sodium and Potassium Oxalate). Internal procedural controls are included in the cassette.

The test has been validated by the manufacturer. Cross-reactivity has been tested for ani-influenza A virus and anti-influenza B virus, anti-RSV, anti-adenovirus, HBsAg, anti-Syphyllis, anit-H.Pylori, and anti-HIV and anti-HCV positive specimens. The results showed no cross-reactivity. Comparing the test with commercially available PCR, the performance results show that 2019-nCoV IgG/IgM Rapid Test Cassette has a high sensitivity and specificity. IgG Results have Relative Sensitivity of 100% (95% confidence interval 86.0-100%), a Relative Specificity of 98.0% (CI 89.4-99.9%), and Accuracy of 98.6% (CI 92.3%-99.96%). IgM Results have Relative Sensitivity of 85.0% (95% CI 62.1%-96.5%), Relative Specificity of 96.0% (95%CI 86.3-99.5%), and Accuracy of 92.9% (95% CI 84.1-97.6%).

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

“These are unprecedented times,” says Phillip Shugart, Chief Executive Officer of Carolina Liquid Chemistries. “The rapid screen is a fast and easy screen for antibodies that compliments other tests and symptoms to give a fuller picture.”

This test should be used for detection of IgG and IgM antibody to 2019- nCoV. Neither the quantitative value nor the rate of increase in the concentration of IgG or IgM antibodies to 2019-nCoV can be determined by this qualitative test. The 2019-nCoV IgG/IgM Rapid Test Cassette (Whole blood/Serum/Plasma) will only indicate the presence of IgG and IgM antibodies to 2019-nCoV in the specimen and should not be used as the sole criteria for the diagnosis of 2019-nCoV infections. As with all diagnostic tests, all results must be considered with other clinical information available to the physician. If the test result is negative and clinical symptoms persist, additional follow-up testing using other clinical methods is suggested. A negative result at any time does not preclude the possibility of 2019-nCoV infection. The test will show negative results under the following conditions: The titer of the novel coronavirus antibodies in the sample is lower than the minimum detection limit of the test, or the novel coronavirus antibody has not appeared at the time of sample collection (Asymptomatic stage).

About Carolina Liquid Chemistries Corp.
Headquartered in Greensboro, NC, Carolina Liquid Chemistries is a ISO 13485:2016 certified manufacturer, repackager/relabeler, distributor, and technical service provider of chemistry systems and reagents for clinical and toxicology laboratories. The company offers chemistry analyzers that range in throughput from 300 to 6,400 tests per hour and markets a wide menu of general chemistry, special chemistry, and toxicology reagents, along with affordable service contracts. For more information, visit or email
1. World Health Organization (WHO). Coronavirus.

Patricia Shugart
Carolina Liquid Chemistries, Corp.
+1 877-722-8910
email us here
Visit us on social media:

Source: EIN Presswire